Tekla Healthcare Investors (HQH) - Cash Flow Conversion Efficiency

Latest as of December 2024: 0.008x

Based on the latest financial reports, Tekla Healthcare Investors (HQH) has a cash flow conversion efficiency ratio of 0.008x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($8.72 Million) by net assets ($1.06 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HQH days of operational coverage to measure how many days the company can operate on defensive assets alone.

Tekla Healthcare Investors - Cash Flow Conversion Efficiency Trend (1996–2014)

This chart illustrates how Tekla Healthcare Investors's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tekla Healthcare Investors Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tekla Healthcare Investors ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Shantou Dongfeng Printing Co Ltd
SHG:601515
-0.004x
Hengerda New Materials (Fujian) Co. Ltd.
SHE:300946
N/A
Invisio Communications AB
ST:IVSO
0.047x
Xinyaqiang Silicon Chemistry Co Ltd
SHG:603155
0.015x
Central Plains Environment Protection Co Ltd
SHE:000544
0.014x
Banpu Power Public Company Limited
BK:BPP
0.009x
BTS Group Holdings Public Company Limited
BK:BTS
0.332x
Universal Insurance Holdings Inc
NYSE:UVE
0.265x

Annual Cash Flow Conversion Efficiency for Tekla Healthcare Investors (1996–2014)

The table below shows the annual cash flow conversion efficiency of Tekla Healthcare Investors from 1996 to 2014. For the full company profile with market capitalisation and key ratios, see Tekla Healthcare Investors stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2014-09-30 $1.05 Billion $-141.08 Million -0.134x -553.81%
2013-09-30 $690.10 Million $20.37 Million 0.030x -42.89%
2012-09-30 $510.40 Million $26.38 Million 0.052x +5.23%
2011-09-30 $378.90 Million $18.61 Million 0.049x +67.01%
2010-09-30 $365.20 Million $10.74 Million 0.029x +493.92%
2009-09-30 $356.30 Million $-2.66 Million -0.007x +53.86%
2008-09-30 $403.00 Million $-6.52 Million -0.016x -39.75%
2007-09-30 $444.00 Million $-5.14 Million -0.012x -8.47%
2006-09-30 $385.10 Million $-4.11 Million -0.011x +16.32%
2005-09-30 $417.10 Million $-5.32 Million -0.013x +3.28%
2004-09-30 $369.30 Million $-4.87 Million -0.013x -13.92%
2003-09-30 $286.80 Million $-3.32 Million -0.012x +25.69%
2002-09-30 $242.00 Million $-3.77 Million -0.016x -109.45%
2001-09-30 $329.40 Million $-2.45 Million -0.007x -39.45%
2000-09-30 $485.60 Million $-2.59 Million -0.005x +59.87%
1998-09-30 $158.00 Million $-2.10 Million -0.013x -65.30%
1997-09-30 $207.70 Million $-1.67 Million -0.008x +41.25%
1996-09-30 $147.60 Million $-2.02 Million -0.014x --

About Tekla Healthcare Investors

NYSE:HQH USA Asset Management
Market Cap
$1.12 Billion
Market Cap Rank
#8788 Global
#2449 in USA
Share Price
$20.19
Change (1 day)
+1.46%
52-Week Range
$15.14 - $20.46
All Time High
$20.46
About

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs funda… Read more